This report summarizes a study into some false positive issues in the use of radioxenon as a method to verify a clandestine nuclear weapons explosion. False positives arise due to similarities between the radioxenon signature generated in medical isotope production and that generated in a nuclear weapon explosion. This report also discusses how to categorize the radioxenon by levels of urgency for manual analysis and interpretation and recommends applying machine learning and time series analysis techniques in the automation of radioxenon characterization. The literature indicates that medical isotope production is a major contributor to atmospheric radioxenon and is the main source of confusion in determining the source of radioxenon. While radioxenon emissions from nuclear power plants can be distinguished from that from nuclear weapon explosions, emissions from medical isotope production generate signatures similar to certain nuclide ratios found in nuclear weapons explosions. Different techniques for analyzing nuclide concentrations and ratios as well as including other sensing modalities via sensor fusion are discussed.
Xe, 133 Xe, 135 Xe). The relative concentrations of these four nuclides can assist analysts in determining whether their source is nuclear power plants (NPPs) or a nuclear weapon explosion (NWE). For example, the ratio of 135 Xe to 133 Xe released by an NWE is orders of magnitude larger for an NWE than that released by an NPP.
Medical isotope production facilities (MIPFs) are another major source of radioxenon. While radioxenon from NWEs can be separated from radioxenon generated from NPPs by analyzing these ratios when levels are detectable, radioxenon from MIPFs is not as easily discriminated from NWEs. A literature search performed on the subject of radioxenon detection suggests that the prevalent view in the CTBT is that medical isotope production can confound analysis techniques that use the four radioxenon nuclides activity to discriminate an NWE from non-weapon sources of radioxenon.
The goal of characterizing radioxenon is to help clarify whether it is coming from an NWE or not. The result of the characterization should be an indication of how interesting a measurement or set of measurements is for this goal and indicate how urgently it needs to be manually analyzed. Overall, the radioxenon characterization product must definitively say "we found something of interest" when there is a reasonable possibility of an NWE.
Radioxenon
Noble gas monitoring and radionuclide particulate monitoring are the only techniques that can potentially provide proof of whether an explosion was nuclear or not . Figure 1 illustrates how radioxenon from NPPs is discriminated from that produced by NWEs through the use of the MIRC plot. A comparison of the radioxenon nuclide ratios from NPPs will show a marked difference from those of NWEs and can be separated by a linear discriminator (i.e., line). This, however, assumes that the four nuclides are at or above the minimum detectable concentration (MDC), which is often not the case. Xe, this report recommends analysts not rely on the four isotope MIRC plot alone, but also work with other activity ratio plots that do not include 131m Xe. Other ratio plots can be generated using Xe. Also, plots of nuclide concentrations-versus-time and nuclide ratios-versus-time are important in radioxenon characterization .
Medical Isotope Production
MIPFs taken as a whole are the most prolific non-weapons emitter of radioxenon, and thus the largest contributor to the background observed by monitoring stations deployed under the CTBT (Saey et al. 2010a) . Three major MIPFs exist in the northern hemisphere: National Research Universal (NRU) at Chalk River, Canada; Institut des Radioéléments (IRE) at Fleurus, Belgium; and the High Flux Reactor (HFR) at Petten, The Netherlands. In the southern hemisphere, the highest radioxenon emitting MIPF is operated by NTP Radioisotopes in Pelindaba, South Africa. The radioxenon emissions from these four MIPFs are given in Table 2 . NRU and HFR produce about one-third each of the world's supply of radiopharmaceuticals. HFR uses an alkaline process for dissolving the uranium targets instead of an acid process, which produces much less radioxenon than the NRU (Saey et al. 2010b; Sameh and Ache 1987) . Tc for use in a wide variety of medical diagnostic procedures. Radioxenon also comes from the production of 131 I, which is used in gamma imaging systems, in the treatment of thyroid diseases, and to diagnose and treat inoperable childhood cancers. Xenon-133 itself is a radiopharmaceutical used in the gamma imaging of the heart, lungs, and brain via SPECT, and also is used to measure blood flow (perfusion) .
When uranium targets are used in the production of these isotopes, the radioxenon emissions from MIPFs have similar nuclide activity ratios to those produced by NWEs, resulting in difficulty discerning the likely source. Figure 2 highlights the region on a MIRC plot where nuclide ratios from MIPFs are found. During the temporary suspension of production at the three major northern hemisphere MIPFs (from mid-2008 until early 2009), analysis showed that MIPFs contributed fifteen times more radioxenon to the atmospheric background than did NPPs (Saey et al. 2010a; ). During that period, measured values of 133 Xe dropped from 4.5 down to 1.1 mBq/m 3 in Freiburg, Germany; and from 2.0 to 1.05 mBq/m 3 in Stockholm, Sweden. These observations resulted in the conclusion that MIPFs are major contributors to the radioxenon background and that the global background is dominated by releases from MIPFs .
Also, according to these observations the maximum detection distance (MDD) was estimated to be about 200 km for NPPs and 7800 km for MIPFs. This was the determined by finding the distance from the MIPFs at which the 133 Xe concentration dropped below 0.3 mBq/m 3 . This indicates that the output from just a few MIPFs in the world should be detectable over the whole IMS network. 
Proposed Methods for Dealing with Medical Isotope Production
Several approaches have been proposed for overcoming the challenges of obtaining accurate detection of potential NWEs with the obfuscation of measurements caused by medical isotope production.
Data Analysis Approach with Existing Data
Several data analysis techniques can be useful in mitigating confusion between an NWE and non-weapon sources. These techniques include time-series analysis, statistical analysis, and machine learning.
The decay process of the different isotopes as determined by time-series analysis, is an important factor in determining its source of origin . There have been some reports of time-series analysis of radioxenon succeeding in discriminating between NWEs and non-weapon sources. Plastino et al.
(2010) performed a study on event classification by using time series radioxenon data detrended with the associated weather phenomenon. With time-series analysis, it is critical to know the amount of time necessary to predict the source type so that a determination can be made in a timely manner in order to respond to the event.
Another, statistical approach uses Bayesian decision methods, which enable inference of the likely source based on prior probabilities of the nuclide ratios . In nuclide ratio analysis, Bayes statistics has an advantage over conventional statistics in that it allows all available prior (a priori) information to be used in the decision process, producing a more robust result.
Machine learning has been applied to simulations of radioxenon sources. reported on the application of "naive Bayes," multilayer perceptron neural networks, decision trees, k-nearest neighbors, and support vector machines that were all trained and tested with simulated activity concentrations of the four nuclides measured in IMS. These machine learning techniques were found to outperform simple linear discriminators in high-radioxenon backgrounds. Further work would be necessary to show their ability to discriminate MIPFs from NWEs and to handle cases where 131m
Xe was below MDC and thus not available for analysis.
Sensor Fusion with other Detection/Sensing Modalities
A basic sensor fusion approach would simply involve combining the findings of the radioxenon detection system, whereas a full sensor fusion approach would include other sensing modalities in CTBTO's IMS. The IMS consists of four parts covering multiple sensor modalities: seismic, hydroacoustic, infrasound, and radionuclides (both particulate and noble gases). Stations in the system are distributed all over the world. Figure 3 plots the locations of the different sensor networks that make up the IMS.
Sensor fusion exploits complementary phenomenology from each detection or sensing modality to produce more useful information than any single modality can provide individually, as diagrammed in Figure 5 . The improved results of this technique derive from both the complementary information unique to each modality and the redundant information common to many or all modalities. While the complementary data increases the information content, the redundant data can be used to reduce artifacts or inconsistencies introduced by the sensor fusion process to reduce false positives while concurrently improving discrimination accuracy. 
Inclusion of Atmospheric Transport Modeling
Atmospheric transport modeling (ATM) would provide modeled information about the probabilities that detected radioxenon was coming from known sources such as NPPs and MIPFs. The ATM would need to include information about all known sources and their locations, as well as current weather information.
One proposed ATM approach would start by flagging a suspicious signature, and then backtrack to known sources (Schöppner et al. 2011) . Next, it would estimate the contributions from known sources to the nearby IMS stations. The contributions of the known sources would then be subtracted from the signals recorded at the nearby IMS stations and fed into an analysis method that would grade the signal with a level indicating the urgency of manual interpretation of the detected signal.
The ATM approach was discussed, but an issue that Dr. Steven Biegalski of the University of Texas at Austin brought up is that a database containing only the unclassified known sources around the world would still result in a classified data base, resulting in the necessity of running the ATM in a classified environment.
Modify procedures in Medical Isotope Production
A fourth option is to modify the medical isotope production process to reduce radioxenon emission from MIPFs.
A one method for doing this is to hold target material longer at the MIPF before using it for production, to allow most of the radioxenon to decay into a stable daughter nuclide. Biegalski showed through simulation that using accumulation tanks to hold irradiated targets would change the radioxenon activity ratios enough to make the isotopes discernible from an NWE . The added benefit of using accumulation tanks is that the activity of the emissions is also reduced. Another option is to add a tracer isotope to the MIPF process to uniquely mark it as a MIPF, though this would raise public concern about adding new emissions. Finally, the most expensive method of reducing radioxenon
Characterization Process
The first three categories discussed in the last section involve analysis of measured IMS data. The goal of the analysis is to indicate the level of likelihood that the measured radioxenon is from an NWE, how much manual interpretation is needed, and the urgency of this interpretation. This output would likely be a set of levels. For example, this range could be from 1 to 5, in which 1 indicates normal background and 5 would indicate that the likelihood of an NWE is great enough to necessitate an immediate manual analysis. Table 3 illustrates this possible set of characterizations with the appropriate responses. Another potential output would be a "traffic light," with levels 1 and 2 being green, 3 being yellow, and 4 and 5 being red. Xe since its concentration can be below the MDC, and 3. the urgency in making a determination of the likelihood of an NWE.
Conclusions
The ability to discriminate radioxenon emissions generated by a nuclear weapon explosion from those emitted by medical isotope productions is key. The most likely near-term solution would rely only on noble gas monitoring, specifically the four radioxenon nuclides used for analysis. Xenon-131m is often below the minimum detectable concentration, but analysis methods must be able to work even when 131m
Xe is not available. The resulting radioxenon characterization system should produce a graded scale as to how significant or interesting the measured radioxenon is and the appropriate level of response.
This report recommends applying both machine-learning methods and time-series analysis of radioxenon activities and ratios. This report also recommends producing a graded level of characterization. A major requirement in performing this recommended study would be the ability to determine the time available to make an analysis and how uncertainties in the data affect the chosen categorization level and time to make the categorization. Ideally, the graded output level would include some indication of confidence in the level chosen.
Beyond these recommendations, this report recommends including sensor fusion with the other IMS sensor modalities. Such a fused analysis would likely produce a more robust distinction between xenon resulting from medical isotope production and that from nuclear weapon explosion.
